Skip to main content
Lazaros Lekakis, MD, Oncology, Miami, FL, University of Miami Hospital

LazarosJLekakisMD

Oncology Miami, FL

Assistant Professor, Medicine, University of Miami Leonard M. Miller School of Medicine

Dr. Lekakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lekakis' full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1999 - 2002
  • University of Athens
    University of AthensClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2025
  • KY State Medical License
    KY State Medical License 2006 - 2011
  • IL State Medical License
    IL State Medical License 1999 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium
    Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma
    Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post_Axi-Cel
    Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other Languages

  • Greek

Hospital Affiliations